Compare ARK Genomic Revolution ETF (ARKG) vs ProShares Ultra Gold ETF (UGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs ProShares Ultra Gold ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.62, while ProShares Ultra Gold ETF trades at $44.06. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ProShares Ultra Gold ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | UGL | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $85.62 |
52-Week Low | $23.09 | $33.59 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
UGL, the ProShares Ultra Gold ETF, trades at $45.76, down 0.74% on the day, reflecting ongoing pressure in the gold market. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators remain neutral. Recent news highlights gold's 25% decline from record highs amid Fed policy uncertainty and geopolitical tensions, though central bank buying provides some support. The ETF's leveraged structure amplifies daily gold price movements, impacting short-term performance.
The outlook for UGL hinges on gold price direction, with near-term risks from rising Treasury yields and inflation data. Opportunities exist if geopolitical tensions or dovish Fed shifts boost gold, but volatility remains high. Investors should note the ETF's decay risk from daily rebalancing in stagnant or volatile markets, making it more suitable for tactical plays than long-term holds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →
